Physician
Cardiology
Dr. Paul S. Teirstein, MD
|
|
Give Review
Paul Teirstein works in the field of Cardiology. He went to medical school at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He has 6 awards "America's Top Doctors", "Top Doctors:San Diego Area", "Top Doctors:Southern California", "Men's Health", "Super Doctor" and "Fellow (FACC)". Paul Teirstein is a published doctor. He published 80 publications, including: 'Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.' Doctor Paul S. Teirstein, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
- One-year results of the ICON (ionic versus non-ionic contrast to obviate worsening nephropathy after angioplasty in Chronic renal failure patients) Study.
- Outcomes After Transfemoral Transcatheter Aortic Valve Replacement: A Comparison of the Randomized PARTNER (Placement of Aortic TraNscathetER Valves) Trial With the NR...
- Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.
- Ballooning the Aortic valve under pressure.
- Three-Year Results Comparing Platinum-Chromium PROMUS Element and Cobalt-Chromium XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Narrowing (from the PLA...
- Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents.
- Stratification of Outcomes after Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons.
- Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial.
- Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy or Embolization: A Study of Multiple Valve Implants in the US PARTNER Trial.
- Procedural Effectiveness of a Novel 1.20?mm Diameter Angioplasty Catheter: Clinical and Angiographic Outcomes.
- Left Main Percutaneous Coronary Intervention.
- Left atrial appendage occlusion for the reduction of stroke and Embolism in patients with atrial fibrillation.
- Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y1...
- Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.
- Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter.
- Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity.
- Drug-eluting stent restenosis: an uncommon yet pervasive problem.
- Comparison of long-term (4-year) outcomes of patients with unprotected left main Coronary artery narrowing treated with drug-eluting stents versus Coronary-artery bypa...
- A novel technique for ultra-low contrast administration during angiography or intervention.
- Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis.
- Dual catheter technique for the treatment of severe Coronary artery perforations.
- Three-year outcome of drug-eluting stent implantation for Coronary artery bifurcation lesions.
- Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.
- Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous Coronary intervention.
- Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in Chronic renal failure patients: the ICON (Ionic vers...
- Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the ...
- Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
- Percutaneous revascularization is the preferred strategy for patients with significant left main Coronary stenosis.
- Safety and performance of targeted renal therapy: the Be-RITe! Registry.
- Change we can believe in: the hyper-evolution of percutaneous Coronary intervention for unprotected left main disease with drug-eluting stents.
- Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous Coronary intervention (data from the Eva...
- The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-m...
- Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.
- A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main Coronary artery disease.
- Unprotected left main intervention: patient selection, operator technique, and clinical outcomes.
- Clopidogrel desensitization after drug-eluting stent placement.
- The truth and consequences of the COURAGE trial.
- Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous Coronary intervention (the REMOVE trial).
- Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable Angina pectoris (a SIRIUS substudy).
- Utility of three-dimensional reconstruction of Coronary angiography to guide percutaneous Coronary intervention.
- IntraCoronary radiation therapy for multi-drug resistant in-stent restenosis: initial clinical experience.
- Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent Failure.
- Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.
- Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions.
- The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
- The dueling hazards of incomplete revascularization and incomplete data.
- Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
- A multicenter, randomized, dose-finding study of gamma intraCoronary radiation therapy to inhibit recurrent restenosis after stenting.
- Rescue percutaneous Coronary intervention early after Coronary artery bypass grafting in the drug-eluting stent era.
- Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main Coronary artery revascularization.
- Percutaneous recanalization of chronically occluded Coronary arteries: a consensus document: part II.
- Percutaneous recanalization of chronically occluded Coronary arteries: a consensus document: part I.
- Percutaneous recanalization of chronically occluded Coronary arteries: procedural techniques, devices, and results.
- Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).
- Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable Angina pectoris or provocable myocardial ischem...
- Percutaneous left Atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic Atrial fibrillation: results from...
- Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions.
- Comparison of Thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
- Relationship of late loss in lumen diameter to Coronary restenosis in sirolimus-eluting stents.
- Aspirin sensitivity: implications for patients with Coronary artery disease.
- Treatment of left anterior descending Coronary artery disease with sirolimus-eluting stents.
- A chicken in every pot and a drug-eluting stent in every lesion.
- Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.
- Paclitaxel prevented restenosis in a totally occluded small vessel with in-stent restenosis: a 9-month angiographic follow-up.
- Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis.
- IntraCoronary radiation to treat in-stent restenosis in six cardiac transplant patients.
- Long-term follow-up of patients after gamma intraCoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III).
- Vascular radiation in a drug-eluting stent world: it's not over till it's over.
- Intravascular brachytherapy for native Coronary ostial in-stent restenotic lesions.
- Pilot trial of oral rapamycin for recalcitrant restenosis.
- Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in Coronary intervention.
- Long-term outcome of patients treated with repeat percutaneous Coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
- A case of an entrapped rotational atherectomy burr.
- Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis...
- Five-year clinical follow-up after intraCoronary radiation: results of a randomized clinical trial.
- A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable Chronic total occlusions.
- Centered versus noncentered source for intraCoronary artery radiation therapy: a model based on the Scripps Trial.
- Restenosis after Angioplasty.
Schools
Mount Sinai School Of Medicine Of New York University
Brigham and Women39s Hospital
Mid Am Heart Institute
National Institute Of Health
Stanford University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:San Diego Area
- Top Doctors:Southern California
- Men's Health
- Super Doctor
- Fellow (FACC)
Education
-
Stanford University -
Brigham and Women's Hospital -
Icahn School of Medicine at Mount Sinai
Hospital
-
NewYork-Presbyterian/Columbia
Drug Facts
| NPI NUMBER | 1548210768 | |
| NPPES Provider LastName | TEIRSTEIN | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 920371027 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiac Surgery | |
| Total Claim Count | 202.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548210768 |
| Last Name Of The Provider | TEIRSTEIN |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Hashim A. Khan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael K. Gilson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marc E. Effron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis A. Goodman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David G. Marsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David B. Meyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merri M. McMahon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Linda M. Couts, NP
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Homan, MD
This Doctor is OpenDoctor Recommended.
|